Project Grant R56HL169223
Award Date
9/26/24
Completion Date
8/31/25
Dollars Obligated
$1M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Columbia, SC 29208, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $126,442 to the Regents of the University of Minnesota to conduct research on the effects of hyperglycemia and recovery on aortic growth and remodeling. The overarching objective is to determine how chronic hyperglycemia impacts aortic biomechanics and mechanobiology, and whether restoration of normoglycemia can reverse...
This $604,795 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate the role of complement-mediated inflammation in promoting worse stroke outcomes in mice with type 2 diabetes. The key objectives are to: 1) determine the functional role of P-selectin and anaphylatoxin receptors in type 2 diabetes-promoted...
This Project Grant award, valued at $1,267,716.00 and funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to investigate the role of red blood cells in stroke-related hyperglycemia. The key objectives of this multiple PI project are: 1) Characterizing acute hyperglycemia-related red blood cell alterations in clinical stroke patients, with a...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is focused on defining the contribution of endothelial cell sphingolipid metabolism to outcomes of acute ischemic stroke in mice. The $192,500 award to the University of Utah aims to (1) determine whether interventions targeting cerebral endothelial cells can improve stroke...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $433,824 to The Leland Stanford Junior University to conduct research on understanding metabolic mechanisms involved in diabetic cardiomyopathy. The project aims to generate induced pluripotent stem cell (iPSC) models of cardiovascular cell types from healthy and type 2 diabetes patients, and evaluate cellular and metabolic phenotypes...
This $624,583 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research at the University of Washington to identify potential therapeutic targets for preventing ischemic stroke. The project will leverage existing plasma samples, genomic data, and electronic medical records from the Heart and Vascular Health Study to evaluate...
This $142,572 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research at Oklahoma State University on the mechanisms underlying obesity-induced hypertension. The grant aims to explore the role of glial cell dysfunction, specifically microglial senescence and impaired astrocyte function in the rostral ventrolateral medulla (RVLM), in driving increased sympathetic nerve activity and hypertension in obesity....
This Project Grant award, totaling $691,614, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant aims to investigate how post-translational modifications of the protein kinase CaMKII during chronic diabetes impact endothelial small-conductance calcium-activated potassium (SK) channel activity, coronary microvascular function, and myocardial blood flow. The research will utilize genetically-modified...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), is funding research to examine a neural circuit in the brain that contributes to the adverse cardiovascular effects of chronic intermittent hypoxia (CIH), a hallmark of obstructive sleep apnea. The research aims to determine how a circuit involving orexin neurons, corticotropin-releasing hormone (CRH) neurons, and neurons in the...
This Project Grant award of $749,360 from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), supports research to investigate the role of the glucose transporter GLUT1 in the development of diabetic cardiomyopathy. The key objectives are to: 1) delineate the signaling events by which GLUT1 leads to diabetic cardiomyopathy, 2) elucidate the cardiotoxic metabolic pathways controlled by GLUT1, and 3) explore the...